Boehringer Ingelheim Archives

News and Trends 21 Apr 2023

RetinAI and Boehringer Ingelheim to use AI to develop treatment for geographic atrophy

RetinAI Medical AG, which creates clinical and imaging data management software and advanced analytics using artificial intelligence (AI) for ophthalmology,…

April 21, 2023 - 2 minutesmins - By Jim Cornall

Best in Biotech 9 Mar 2023

5 advancements in kidney disease research over the past year

Prevalent in millions of people across the globe, kidney diseases manifest through various symptoms like blood and excess protein in…

March 9, 2023 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 9 Jan 2023

Boehringer Ingelheim and 3T Biosciences to develop next-generation cancer immunotherapies

Boehringer Ingelheim and 3T Biosciences have entered into a strategic collaboration and licensing agreement to discover and develop next-generation cancer…

January 9, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 2 Sep 2022

Psoriasis pustules disappear in over half of patients using Boehringer Ingelheim drug

More than half of patients treated for psoriasis with an intravenous injection showed no visible pustules just one week after…

September 2, 2022 - 2 minutesmins - By Liza Laws

Diagnostic Test Mobidiag Antimicrobial Resistance

News and Trends 7 Jul 2022

Three companies join forces to tackle antimicrobial resistance (AMR)

A joint venture to create the next generation of antimicrobials, along with actionable diagnostics to fight AMR, has been announced…

July 7, 2022 - 4 minutesmins - By Liza Laws

In Depth 22 Nov 2021

How Will We Be Treating Cystic Fibrosis 10 Years From Now?

Current treatments for cystic fibrosis are not suitable for all patients and have a limited effect on this life-threatening disease.…

November 22, 2021 - 9 minutesmins - By Clara Rodríguez Fernández

News and Trends 11 May 2021

ADC Approval Buoys Spirits in Cancer Treatment Space

The FDA recently approved an antibody-drug conjugate drug from ADC Therapeutics as a treatment for blood cancer. This has given…

May 11, 2021 - 7 minutesmins - By Jonathan Smith

boehringer ingelheim cancer vaccine amal therapeutics

News and Trends 16 Jul 2019

Boehringer Ingelheim Acquires Cancer Vaccine Biotech in €325M Deal

The German giant Boehringer Ingelheim has acquired the Swiss company AMAL Therapeutics and its cancer vaccine technology in a deal…

July 16, 2019 - 2 minutesmins - By Jonathan Smith

Boehringer Ingelheim ViraTherapeutics oncolytic virus

More News! 13 Sep 2018

Boehringer Ingelheim Acquires Oncolytic Virus Biotech Company

Boehringer Ingelheim is paying €210M to acquire all the remaining shares of ViraTherapeutics, an Austrian biotech company developing oncolytic viral…

September 13, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

OSE Immunotherapeutics Boehringer Ingelheim

News and Trends 5 Apr 2018

Boehringer Offers €1Bn for New Checkpoint Inhibitor from a French Biotech

OSE Immunotherapeutics could receive up to €1.1Bn from its new partner Boehringer Ingelheim, which has set its eyes on a…

April 5, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 12 Feb 2018

No Nonsense Boehringer Ingelheim Jettisons Failing Alzheimer’s Disease Drug

Boehringer Ingelheim has ditched its Alzheimer's drug after it failed to meet the endpoints of a Phase II trial but…

February 12, 2018 - 3 minutesmins - By Alex Dale

News and Trends 4 Jan 2018

Boehringer Ingelheim Doubles its Venture Fund for Exciting Biotech

Boehringer Ingelheim has committed to continue helping young companies grow by doubling the size of its venture fund to €250M, which…

January 4, 2018 - 2 minutesmins - By Alex Dale

News and Trends 19 Dec 2017

Schizophrenia and Drug Delivery Biotechs Sign a Major Pharma Partner

Santa Claus is not the only busy one in the weeks leading up to Christmas this year, with Boehringer Ingelheim…

December 19, 2017 - 2 minutesmins - By Alex Dale

News and Trends 8 Nov 2017

German Pharma and Biotech Gang Up on NASH in an Exciting Collaboration

Boehringer Ingelheim's fight against liver disease is taking shape, having agreed on a partnership with RNA pioneer MiNA Therapeutics to…

November 8, 2017 - 3 minutesmins - By Alex Dale

News and Trends 18 Sep 2017

German Humira Biosimilar for Inflammatory Diseases Cleared for EMA Approval

Cyltezo, an adalimumab biosimilar drug by Boehringer Ingelheim, has received the backing to be marketed in Europe. The EMA's Committee…

September 18, 2017 - 1 minutemin - By Alex Dale

Inventiva fibrosis abbvie boehringer ingelheim

News and Trends 5 Sep 2017

French Biotech Lures Big Pharma with Fibrosis Treatments

This week, Inventiva has received a milestone payment from Boehringer Ingelheim and extended its collaboration with AbbVie. Today, Boehringer Ingelheim has decided…

September 5, 2017 - 1 minutemin - By Clara Rodríguez Fernández